GW Pharmaceuticals plc (GWPH) Soars: Stock Up 13.9%

Zacks Equity Research
April 24, 2014

GW Pharmaceuticals plc (GWPH) was a big mover last session, as its shares rose nearly 14% on the day. The rise came on solid volume too with far more shares changing hands than in a normal session. This breaks the trend for the company since Apr 3, as the stock is now trading above the volatile price range of $44.00 to $60.86.

In the last 30 days, the company has not seen any estimate revision and the Zacks Consensus Estimate also remained unchanged. However, yesterday’s price action is encouraging, so make sure to keep a close watch on this firm in the near future.

GW Pharmaceuticals currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.

Better-ranked medical stocks include Edwards Lifesciences Corp. (EW), Enzymotec Ltd. (ENZY) and Venaxis, Inc. (APPY). While Edwards Lifesciences and Venaxis carry a Zacks Rank #2 (Buy), Enzymotec sports a Zacks Rank #1 (Strong Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>




GW PHARMACEUTICALS PLC ADS (GWPH): Free Stock Analysis Report

VENAXIS INC (APPY): Free Stock Analysis Report

EDWARDS LIFESCIENCES CORP (EW): Free Stock Analysis Report

ENZYMOTEC LTD ORD (ENZY): Free Stock Analysis Report


Zacks Investment Research